Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE: 600613)
Health Care · Pharmaceuticals · CN
CN¥8.72
+6.47% today · +42.0% 1Y
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE: 600613) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $648.15M and employs 1,196 people.
Over the last twelve months the share price has gained 42.0%, trading between 4.33 and 12.77.
Tweenvest scores Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. across four factors: quality 76/100, value 20/100, growth 0/100, dividend 46/100. Its strongest factor is quality.
600613 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $648.15M
- Revenue (TTM)
- $270.82M
- P/E
- 174.24
- EPS
- 0.05
- Dividend yield
- 0.80%
- Beta (5Y)
- 0.61
- 52-week high
- CN¥12.77
- 52-week low
- CN¥4.33
- Avg volume (3M)
- —
- Shares outstanding
- 534.07M
- Employees
- 1,196
- Next earnings
- —
About Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., through its various subsidiaries, functions as a pharmaceutical manufacturing holding and investment entity within China. The company's operations encompass the research, development, and production of a broad spectrum of medications. Its therapeutic focus includes pharmaceuticals for oncology, cardiovascular and cerebrovascular conditions, respiratory issues (such as colds and coughs), pediatric care, and antifungal treatments, alongside general health tonics. The firm's product portfolio features both prescription-only drugs and readily available over-the-counter (OTC) remedies. Established in Shanghai, China, in 1992, the company continues to operate from this location.
- ISIN
- CNE000000453
- Founded
- 1992
- Listed since
- Aug 20, 1992
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sinotherapeutics Inc.SHSE: 688247 | $668.33M | CN¥9.97 | -1.19% |
| PT Tempo Scan Pacific TbkIDX: TSPC | $662.85M | Rp2,630.00 | -0.38% |
| Tianjin Lisheng Pharmaceutical Co.,Ltd.SZSE: 002393 | $655.52M | CN¥14.25 | +1.21% |
| Zhejiang Sunflower Great Health Co., Ltd.SZSE: 300111 | $655.32M | CN¥3.41 | +14.43% |
| Handa Pharmaceuticals, Inc.TPEX: 6620 | $648.08M | NT$127.50 | -11.15% |
| Chong Kun Dang Pharmaceutical Corp.KOSE: A185750 | $645.88M | ₩65,900.00 | +1.07% |
| LanZhou Foci Pharmaceutical Co.,Ltd.SZSE: 002644 | $639.65M | CN¥8.39 | +1.57% |
| Chimin Health Management Co., Ltd.SHSE: 603222 | $636.24M | CN¥8.30 | +2.85% |
Figures last refreshed Oct 11, 2026.